Literature DB >> 18201467

Urachal tumour: clinical and radiological features of a poorly understood carcinoma.

Athanasios Tsiouris1, Hashim Uddin Ahmed, Nittin Kumar, Amir V Kaisary.   

Abstract

Urachal tumours are rare vesical neoplasms. We report a case of urachal adenocarcinoma in a 31-year-old patient.

Entities:  

Mesh：

Year:  2007        PMID： 18201467      PMCID： PMC2121234          DOI： 10.1308/147870807X227764

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


  3 in total

Review 1.  Urachal remnants: an enigma.

Authors:  V Upadhyay; A Kukkady
Journal:  Eur J Pediatr Surg       Date:  2003-12       Impact factor: 2.191

2.  Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience.

Authors:  Arlene O Siefker-Radtke; Jason Gee; Yu Shen; Sijin Wen; Danai Daliani; Randall E Millikan; Louis L Pisters
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

3.  Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.

Authors:  Richard A Ashley; Brant A Inman; Thomas J Sebo; Bradley C Leibovich; Michael L Blute; Eugene D Kwon; Horst Zincke
Journal:  Cancer       Date:  2006-08-15       Impact factor: 6.860
  3 in total
  4 in total

1.  Urachal adenocarcinoma incidentally discovered in a young woman at elective caesarean section.

Authors:  Hariette Goldman; Steven Sowter
Journal:  BMJ Case Rep       Date:  2016-06-28

Review 2.  Umbilical complications of malignancy.

Authors:  Mark A Marinella
Journal:  J Gastrointest Cancer       Date:  2009-02-13

3.  Urachal Cyst Causing Small Bowel Obstruction in an Adult with a Virgin Abdomen.

Authors:  Michael P O'Leary; Zane W Ashman; David S Plurad; Dennis Y Kim
Journal:  Case Rep Surg       Date:  2016-11-09

Review 4.  Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Authors:  Henning Reis; Ulrich Krafft; Christian Niedworok; Orsolya Módos; Thomas Herold; Mark Behrendt; Hikmat Al-Ahmadie; Boris Hadaschik; Peter Nyirady; Tibor Szarvas
Journal:  Dis Markers       Date:  2018-03-12       Impact factor: 3.434
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.